Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05KNG
|
||||
Former ID |
DIB011063
|
||||
Drug Name |
ALB-109564(a)
|
||||
Synonyms |
ALB-109564; Vinca alkaloid analogs (cancer), Albany Molecular Research
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [522388] | ||
Company |
Bessor-brightwaters pharma
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
Cl.Cl.C(=O)([C@]1(c2c(c3c([nH]2)ccc(c3)SC)CCN2C[C@](C[C<br />@@H](C1)C2)(O)CC)c1cc2[C@@]34[C@H]([C@]([C@@H]([C@]5([C<br/>@@H]3N(CC4)CC=C5)CC)OC(=O)C)(C(=O)OC)O)N(c2cc1OC)C)OC
|
||||
Target and Pathway | |||||
Target(s) | Tubulin beta | Target Info | Modulator | ||
PANTHER Pathway | Cytoskeletal regulation by Rho GTPase | ||||
Huntington disease | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.